Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T14357 |
Spebrutinib besylate
CC-292 (besylate),AVL-292 (benzenesulfonate) |
BTK | Angiogenesis; Tyrosine Kinase/Adaptors |
Spebrutinib besylate (AVL-292 benzenesulfonate; CC-292 besylate) is a Btk kinase activity inhibitor (IC50<0.5 nM, Kinact/Ki=7.69×104 M-1s-1s). | |||
T2603 |
Spebrutinib
CC-292,LMK-435,AVL-292 |
Src; BTK | Angiogenesis; Tyrosine Kinase/Adaptors |
Spebrutinib (LMK-435) 是一种共价的、高效的、选择性的、具有口服活性的Btk 抑制剂 (IC50:0.5 nM)。 |